{
  "model_name": "Qwen/Qwen3-4B-Instruct-2507",
  "article_id": "longhealth_group_01_patients_06-10",
  "question_ids": [
    "patient_06_q0",
    "patient_06_q1",
    "patient_06_q2",
    "patient_06_q3",
    "patient_06_q4",
    "patient_06_q5",
    "patient_06_q6",
    "patient_06_q7",
    "patient_06_q8",
    "patient_06_q9",
    "patient_06_q10",
    "patient_06_q11",
    "patient_06_q12",
    "patient_06_q13",
    "patient_06_q14",
    "patient_06_q15",
    "patient_06_q16",
    "patient_06_q17",
    "patient_06_q18",
    "patient_06_q19",
    "patient_07_q0",
    "patient_07_q1",
    "patient_07_q2",
    "patient_07_q3",
    "patient_07_q4",
    "patient_07_q5",
    "patient_07_q6",
    "patient_07_q7",
    "patient_07_q8",
    "patient_07_q9",
    "patient_07_q10",
    "patient_07_q11",
    "patient_07_q12",
    "patient_07_q13",
    "patient_07_q14",
    "patient_07_q15",
    "patient_07_q16",
    "patient_07_q17",
    "patient_07_q18",
    "patient_07_q19",
    "patient_08_q0",
    "patient_08_q1",
    "patient_08_q2",
    "patient_08_q3",
    "patient_08_q4",
    "patient_08_q5",
    "patient_08_q6",
    "patient_08_q7",
    "patient_08_q8",
    "patient_08_q9",
    "patient_08_q10",
    "patient_08_q11",
    "patient_08_q12",
    "patient_08_q13",
    "patient_08_q14",
    "patient_08_q15",
    "patient_08_q16",
    "patient_08_q17",
    "patient_08_q18",
    "patient_08_q19",
    "patient_09_q0",
    "patient_09_q1",
    "patient_09_q2",
    "patient_09_q3",
    "patient_09_q4",
    "patient_09_q5",
    "patient_09_q6",
    "patient_09_q7",
    "patient_09_q8",
    "patient_09_q9",
    "patient_09_q10",
    "patient_09_q11",
    "patient_09_q12",
    "patient_09_q13",
    "patient_09_q14",
    "patient_09_q15",
    "patient_09_q16",
    "patient_09_q17",
    "patient_09_q18",
    "patient_09_q19",
    "patient_10_q0",
    "patient_10_q1",
    "patient_10_q2",
    "patient_10_q3",
    "patient_10_q4",
    "patient_10_q5",
    "patient_10_q6",
    "patient_10_q7",
    "patient_10_q8",
    "patient_10_q9",
    "patient_10_q10",
    "patient_10_q11",
    "patient_10_q12",
    "patient_10_q13",
    "patient_10_q14",
    "patient_10_q15",
    "patient_10_q16",
    "patient_10_q17",
    "patient_10_q18",
    "patient_10_q19"
  ],
  "question_ids_hash": "20469f08d1d97d63",
  "max_new_tokens": 2048,
  "generations": [
    {
      "question_id": "patient_06_q0",
      "generated_text": "The diagnosis states \"left midline tongue carcinoma\" and \"left base of the tongue\" in the initial text.\n\nC"
    },
    {
      "question_id": "patient_06_q1",
      "generated_text": "The patient's diagnoses include: non-insulin-dependent diabetes mellitus type II, idiopathic thrombocytopenia, liver cirrhosis, and hypothyroidism. Insulin-dependent diabetes mellitus type I is not listed among the diagnoses.\n\nD"
    },
    {
      "question_id": "patient_06_q2",
      "generated_text": "The question asks which nerve was meticulously preserved during the neck dissection for Mr. Paul Doe.\n\nLooking at the surgical report in the provided text, it states: \"Throughout this process, careful attention was paid to sparing the aforementioned neural and vascular structures. Subsequently, access to the lateral pharynx wall was gained, allowing visualization of the external carotid artery along with its branches, including the superior thyroid artery, superior laryngeal artery, and lingual artery. Notably, the lingual artery was interrupted during this stage. Further exploration revealed the superior laryngeal nerve and hypoglossal nerve intersecting in a loop above the internal carotid artery and externally below the external jugular vein. Additional dissection in a ventral direction followed. The hypoglossal nerve was prepared meticulously. Exposure of the hyoid bone was achieved, with a posterior resection of half of the hyoid bone. Importantly, the hypoglossal nerve was spared during this procedure.\"\n\nThe text explicitly states that the hypoglossal nerve was prepared meticulously and was spared.\n\nTherefore, the correct answer is C.\n\nC"
    },
    {
      "question_id": "patient_06_q3",
      "generated_text": "The frozen section report states: \"Invasive, moderately differentiated, squamous cell carcinoma with keratinization of the medial left base of the tongue, maximum extent 1.0 cm. ... The cell nuclei are enlarged, round to oval, with occasional small nucleoli and mild to moderate nuclear pleomorphism. Dyskeratosis is observed in some areas.\"\n\nFeatures observed:\n- Intercellular bridges (implied by \"invasive growth with solid clusters\" and \"intercellular bridges\" mentioned in microscopy)\n- Enlarged nuclei (explicitly stated)\n- Nuclear pleomorphism (explicitly stated)\n- Dyskeratosis (explicitly stated)\n\nFeature NOT observed: Presence of large vacuoles \u2014 this is not mentioned in the report.\n\nD"
    },
    {
      "question_id": "patient_06_q4",
      "generated_text": "The patient Paul Doe underwent radiotherapy from 07/27/2014 to 09/06/2014, as stated in the text: \"Radiotherapy 07/27/2014 - 09/06/2014\".\n\nC"
    },
    {
      "question_id": "patient_06_q5",
      "generated_text": "The question asks for the histological size of the metastatic recurrence from the previously known hypopharyngeal carcinoma in Paul Doe.\n\nLooking through the provided texts, the relevant information is in text_5 and text_6, which discuss the metastatic recurrence. In text_5, under \"Histology Report,\" it states: \"Resected left upper lobe specimen with a 2.9 cm solid carcinoma.\"\n\nThis directly gives the size of the resected metastatic lesion.\n\nTherefore, the correct answer is D.\n\nD"
    },
    {
      "question_id": "patient_06_q6",
      "generated_text": "The question asks for the result of Mr. Doe's Creatinine lab test. I need to look through the provided documents for Mr. Paul Doe and find the Creatinine value.\n\nLooking at the text, there are multiple documents about Mr. Paul Doe. In the document dated 09/24/2021 (text_4), under \"Lab results upon Discharge\", there is a line: \"Creatinine 1.32 mg/dL\".\n\nThis matches the question about Mr. Doe's Creatinine lab test.\n\nA. 1.2 mg/dL\nB. 0.97 mg/dL\nC. 1.27 mg/dL\nD. 1.32 mg/dL\nE. 1.72 mg/dL\n\nThe correct answer is D.\n\nD"
    },
    {
      "question_id": "patient_06_q7",
      "generated_text": "The text mentions that Mr. Doe received radiotherapy in 2015 with a total dose of 60 Gy in a \"single dose of 2 Gy\" up to a total dose of 60 Gy. This indicates that each session was 2 Gy.\n\nB"
    },
    {
      "question_id": "patient_06_q8",
      "generated_text": "Step 1: Identify the relevant discharge lab results for Mr. Paul Doe in January 2022. This is found in text_5, which reports lab results upon discharge for Mr. Paul Doe.\n\nStep 2: Look at the hematology values listed in text_5:\n- WBC: 6,900 /\u03bcL (normal range: 4,500 - 11,000 /\u03bcL) \u2192 within normal limits\n- RBC: 2.7M /\u03bcL (normal: 4.5M - 5.9M /\u03bcL) \u2192 below normal\n- Hemoglobin: 8.2 g/dL (normal: 14 - 18 g/dL) \u2192 below normal\n- Hematocrit: 25.1 % (normal: 40 - 48 %) \u2192 below normal\n- MCH: 31.27 pg (normal: 27 - 33 pg) \u2192 within normal limits\n- MCV: 94 fL (normal: 82 - 92 fL) \u2192 above normal\n- MCHC: 32.7 g/dL (normal: 32 - 36 g/dL) \u2192 within normal limits\n- Platelets: 638,000 /\u03bcL (normal: 150,000 - 450,000 /\u03bcL) \u2192 above normal\n\nStep 3: Determine which of the listed options (A, B, C, D, E) is abnormal.\n- A. WBC: 6,900 \u2192 normal\n- B. Lymphocytes: not listed in the discharge results\n- C. MCH: 31.27 \u2192 normal\n- D. MCV: 94 \u2192 above normal (abnormal)\n- E. Platelets: 638,000 \u2192 above normal (abnormal)\n\nStep 4: The question asks for an abnormal hematology result. Both MCV and Platelets are above normal. However, MCV (94 fL) is slightly above the upper limit (92 fL), and platelets (638,000) are significantly above the upper limit (450,000). Both are abnormal, but platelets are more clearly abnormal.\n\nBut note: the question asks for \"an abnormal\" result, not \"the most abnormal.\" Both D and E are abnormal. However, MCV is 94 fL, which is just above the upper limit (92 fL), and platelets are 638,000, which is well above the upper limit.\n\nGiven that platelets are clearly outside the normal range and MCV is at the edge, platelets are more definitively abnormal.\n\nD. MCV is slightly abnormal, E. Platelets are clearly abnormal.\n\nBut the options are: A. WBC, B. Lymphocytes (not listed), C. MCH (normal), D. MCV (slightly abnormal), E. Platelets (abnormal)\n\nSince platelets are clearly abnormal and listed, and MCV is borderline, the best answer is E.\n\nE"
    },
    {
      "question_id": "patient_06_q9",
      "generated_text": "The chest X-ray dated January 21st, 2022, mentioned in the text states: \"Left apical pneumothorax, measuring approximately 2.3 cm.\"\n\nA"
    },
    {
      "question_id": "patient_06_q10",
      "generated_text": "The question asks about lab results upon discharge in January 2022 for Paul Doe, specifically which value was elevated.\n\nLooking at the provided text, the relevant lab results are found in text_5, which describes Paul Doe's discharge in January 2022. The lab results listed are:\n\n- Sodium: 141 mEq/L (within normal range)\n- Potassium: 4.7 mEq/L (within normal range)\n- Creatinine: 1.1 mg/dL (within normal range)\n- eGFR (MDRD): >60 mL/min/1.73m\u00b2 (normal)\n- eGFR (CKD-EPI): 85 mL/min/1.73m\u00b2 (normal)\n- C-Reactive Protein: 5.0 mg/dL (elevated, as normal is <0.5 mg/dL)\n\nC-reactive protein (CRP) is elevated at 5.0 mg/dL, which is significantly above the normal reference range of <0.5 mg/dL.\n\nAll other values are within normal ranges.\n\nE"
    },
    {
      "question_id": "patient_06_q11",
      "generated_text": "The question asks for Mr. Paul Doe's hemoglobin level upon discharge in September 2021.\n\nLooking at the provided texts, the only one that mentions a hemoglobin level in September 2021 is text_4, which is dated 09/24/2021. In that text, under \"Lab results upon Discharge\", the hemoglobin value is listed as 8.2 g/dL.\n\nTherefore, the correct answer is B.\n\nB"
    },
    {
      "question_id": "patient_06_q12",
      "generated_text": "The histology report from the resected left upper lobe specimen on 01/10/2022 states: \"Resected left upper lobe specimen with a 2.9 cm solid carcinoma. The histological picture is consistent with a metastasis from the previously diagnosed non-keratinizing squamous cell carcinoma. There were focal vascular invasions. No pleural invasion was observed.\"\n\nStep-by-step:\n- The report explicitly states \"focal vascular invasions\" \u2192 this matches option D.\n- It says \"no pleural invasion\" \u2192 eliminates B.\n- It states the carcinoma is from a non-keratinizing squamous cell carcinoma \u2192 eliminates A.\n- It says the dissected lymph nodes were free of tumor \u2192 eliminates C.\n\nTherefore, the correct answer is D.\n\nD"
    },
    {
      "question_id": "patient_06_q13",
      "generated_text": "The patient is Mr. Paul Doe, and the question asks for the date he presented to the outpatient clinic for phoniatrics and pedaudiology.\n\nLooking through the provided texts, in text_2, we find a report about Mr. Paul Doe presenting to the outpatient clinic for phoniatrics and pedaudiology on 10/10/2014.\n\nTherefore, the correct answer is:\n\nC"
    },
    {
      "question_id": "patient_06_q14",
      "generated_text": "The issue with the Provox voice prosthesis arose after the patient completed adjuvant radiotherapy. According to text_2, the patient underwent adjuvant radiotherapy and \"after completion of the adjuvant radiotherapy approximately 6 weeks ago, phonation via the Provox voice prosthesis was no longer possible.\" This indicates that the issue arose about 6 weeks after radiotherapy.\n\nD"
    },
    {
      "question_id": "patient_06_q15",
      "generated_text": "The latest report provided is from text_5, which states: \"Patient in reduced general condition (KPS 60%, 86 kg, 188 cm).\" \n\nThis directly states Mr. Doe's weight as 86 kg.\n\nD"
    },
    {
      "question_id": "patient_06_q16",
      "generated_text": "The text states: \"Panendoscopy with sampling on 04/14/2014 and 04/26/2014\" which led to the initial diagnosis of the left tongue base carcinoma.\n\nTherefore, the panendoscopy was performed in April 2014.\n\nB"
    },
    {
      "question_id": "patient_06_q17",
      "generated_text": "The question asks for Mr. Paul Doe's hematocrit level from the lab results on 09/2021.\n\nLooking through the provided text, in the document labeled <text_4>, under the section \"Lab results upon Discharge\", there is a table listing lab parameters. The hematocrit value listed is 25.1%.\n\nTherefore, the correct answer is:\n\nB"
    },
    {
      "question_id": "patient_06_q18",
      "generated_text": "The question asks about recommendations for dental procedures after head and neck radiation therapy for Mr. Paul Doe.\n\nLooking through the provided texts, in text_1, under \"Current Recommendations\", it states: \"For patients who have completed radiation therapy in the ENT region, we advise lifelong adherence to fluoride prophylaxis and antibiotic therapy during any dental procedures.\"\n\nThis directly matches option C: \"Regular fluoridation of the teeth and guideline-based antibiotic prophylaxis prior to major dental procedures.\"\n\nA, B, D, and E are not mentioned in the texts.\n\nC"
    },
    {
      "question_id": "patient_06_q19",
      "generated_text": "The imaging tests for Paul Doe are listed in chronological order in the documents:\n\n1. CT chest, abdomen, pelvis on 05/28/14\n2. CT neck on 06/11/14\n3. Ultrasound abdomen on 06/15/14\n4. X-ray pap swallow on 06/17/14\n5. MRI neck is not explicitly mentioned in the text, but MRI is not performed; the only imaging mentioned after CT neck is ultrasound abdomen and X-ray swallow.\n6. CT chest is not explicitly mentioned; however, the text mentions \"CT chest/abdomen/pelvis\" and \"CT neck\", not \"CT chest\" alone.\n\nLooking at the options, option E includes CT chest/abdomen/pelvis, CT neck, MRI neck, MRI neck, CT chest, ultrasound abdomen, chest X-ray, chest X-ray, chest X-ray \u2014 but MRI neck is not mentioned in the text.\n\nOption A has MRI neck before CT chest/abdomen/pelvis, which is incorrect.\n\nOption B has CT chest/abdomen/pelvis first, then CT neck, then ultrasound abdomen, then X-ray swallow \u2014 this matches the order.\n\nOption C starts with CT neck, which is after CT chest/abdomen/pelvis, so it's incorrect.\n\nOption D starts with chest X-ray, which is not the first test.\n\nOption E has MRI neck before CT chest/abdomen/pelvis, which is incorrect.\n\nThe correct chronological order from the text is:\n- CT chest, abdomen, pelvis\n- CT neck\n- Ultrasound abdomen\n- X-ray swallow\n\nThus, option B is the closest, though it includes MRI neck which is not in the text. However, among the options, B has the correct sequence of the mentioned tests.\n\nB"
    },
    {
      "question_id": "patient_07_q0",
      "generated_text": "Step by step:\n\n1. The patient is Mrs. Linda Mayer, diagnosed with left breast carcinoma.\n2. The tumor board decision from 07/13/2019 states:\n   - If no metastasis (M0): Fast-track BRCA testing is recommended.\n   - If BRCA testing returns negative: Proceed with a selective excision of the left breast after ultrasound-guided fine needle marking and sentinel lymph node biopsy on the left side. Additionally, perform Endopredict analysis on the surgical specimen.\n3. The question asks for the course of action if BRCA testing returns negative.\n4. The exact recommendation in that scenario is selective excision with sentinel lymph node biopsy.\n\nAnswer: C"
    },
    {
      "question_id": "patient_07_q1",
      "generated_text": "The MRI from 07/11/2019 identified a unifocal lesion on the lower left exterior measuring approximately 2.4 cm in size.\n\nA. 6 mm\nB. 17 mm\nC. 2.2 cm\nD. 2.4 cm\nE. 7x5mm\n\nThe correct answer is D. 2.4 cm.\n\nD"
    },
    {
      "question_id": "patient_07_q2",
      "generated_text": "Step 1: Identify the relevant patient and diagnosis. The patient is Mrs. Linda Mayer, and the diagnosis is left breast carcinoma.\n\nStep 2: Look for the Ki67 labeling index in the text. In the text under \"text_4\", the relevant section states: \"Ki67:15%, BRCA 2 mutation.\"\n\nStep 3: Confirm the value. The Ki67 labeling index is explicitly stated as 15%.\n\nStep 4: Match to the options. Option B is 15%.\n\nB"
    },
    {
      "question_id": "patient_07_q3",
      "generated_text": "Step 1: Identify the patient and the relevant diagnosis. The patient is Mrs. Linda Mayer, and the diagnosis is breast carcinoma.\n\nStep 2: Review the \"Other Diagnoses\" listed in the text for Mrs. Linda Mayer. These are:\n- Hailey-Hailey disease\n- History of apoplexy in 2016\n- Right hip total hip replacement\n- History of left adnexectomy in 1980 due to extrauterine pregnancy\n- Tubal sterilization in 1988\n- Uterine curettage (Abrasio) in 2004\n- Hysterectomy in 2005\n- Depressive episodes\n\nStep 3: Check which of the options listed is not in the list of other diagnoses.\n- A. Hailey-Hailey disease \u2192 present\n- B. History of apoplexy in 2016 \u2192 present\n- C. Right hip total hip replacement \u2192 present\n- D. Chronic obstructive pulmonary disease (COPD) \u2192 not listed\n- E. History of left adnexectomy in 1980 due to extrauterine pregnancy \u2192 present\n\nStep 4: COPD is not mentioned in any of the provided history for Mrs. Linda Mayer.\n\nAnswer: D"
    },
    {
      "question_id": "patient_07_q4",
      "generated_text": "Step by step:\n\n- The question asks about a complication during a VAC (Vacuum-Assisted Closure) change in Mrs. Linda Mayer.\n- In the surgical report for Mrs. Mayer (text_4), the VAC change is described in a section titled \"Surgery Report (Vac Change + Irrigation)\".\n- It states: \"Indication for VAC change. After a detailed explanation of the procedure, its risks, and alternatives, the patient agrees to the proposed procedure.\"\n- Then: \"The course of surgery: Proper positioning in a supine position. Removal of the VAC sponge. A foul odor appears from the wound cavity. Careful disinfection of the surgical area. Sterile draping. Detailed inspection of the wound conditions. Wound debridement with removal of fibrin coatings and freshening of the wound. Resection of necrotic material in places with sharp spoon. Followed by extensive Irrigation of the entire wound bed and wound edges using 1 l Polyhexanide solution. Renewed VAC sponge application according to standard.\"\n- The foul odor and the need for debridement and irrigation suggest a wound with necrotic tissue, which is a sign of infection.\n- There is no mention of hemorrhage, extracapsular spread, anaphylaxis, or adhesion formation directly related to the VAC change.\n- The foul odor and necrotic tissue point to infection.\n\nAnswer: B"
    },
    {
      "question_id": "patient_07_q5",
      "generated_text": "The lab results for Linda Mayer in September 2019 show the following relevant parameters:\n\n- Hemoglobin: 11.1 g/dL (normal range: 12.0\u201315.6 g/dL) \u2192 slightly low\n- Sodium: 141 mEq/L (normal range: 132\u2013146 mEq/L) \u2192 normal\n- Albumin: 4.09 g/dL (normal range: 3.5\u20135.2 g/dL) \u2192 normal\n- Creatinine: 0.82 mg/dL (normal range: 0.50\u20130.90 mg/dL) \u2192 normal\n- 25-OH-Vitamin D3: 91.7 nmol/L (normal range: 50.0\u2013150.0 nmol/L) \u2192 normal\n\nHemoglobin is slightly below the normal range, indicating mild anemia. While not severely abnormal, it is the only parameter outside the normal range.\n\nA"
    },
    {
      "question_id": "patient_07_q6",
      "generated_text": "Step 1: Identify the relevant discharge lab results for Mrs. Linda Mayer in September 2019.\nStep 2: Look for any parameter that was elevated beyond the reference range.\nStep 3: Check the values in the provided text.\n\nIn the text for text_4, under \"Lab results upon Discharge\", we see:\n- CRP: 2.9 mg/dL (reference: <0.5 mg/dL) \u2192 elevated\n- Other values are within normal range.\n\nAnswer: C"
    },
    {
      "question_id": "patient_07_q7",
      "generated_text": "Step by step:\n\n1. The question asks which bacterial organism was NOT identified in Mrs. Linda Mayer's lesional skin swab.\n2. Looking at the relevant text (text_5), under \"MRSA Smears\", it states:\n   - Nasal Smear: Normal flora, no MRSA.\n   - Throat Swab: Normal flora, no MRSA.\n   - Non-lesional Skin Swab: Normal flora.\n   - Lesional Skin Swab: Abundant Pseudomonas aeruginosa, abundant Klebsiella oxytoca, and abundant Serratia sp.\n3. The organisms identified in the lesional skin swab are:\n   - Pseudomonas aeruginosa\n   - Klebsiella oxytoca\n   - Serratia sp.\n4. MRSA was not found in any swab (nasal, throat, non-lesional, or lesional).\n5. Escherichia coli is not mentioned in any swab result.\n6. Since the question is about the lesional skin swab specifically, and E. coli is not listed as being found there, and MRSA was not found either, we must determine which one was NOT identified.\n7. However, in the lesional skin swab, E. coli is not mentioned at all, while MRSA is explicitly stated to be absent.\n8. The text says \"abundant\" for Pseudomonas, Klebsiella, and Serratia, but says \"no MRSA\" in the lesional swab.\n9. Therefore, MRSA was NOT identified in the lesional skin swab.\n10. E. coli is not mentioned in any swab, so it's also not identified.\n\nBut the question is: which was NOT identified in the lesional skin swab?\n\nThe text explicitly states: \"Lesional Skin Swab: Abundant Pseudomonas aeruginosa, abundant Klebsiella oxytoca, and abundant Serratia sp.\" \u2014 so these three ARE identified.\n\nIt says: \"no MRSA\" \u2014 so MRSA was NOT identified.\n\nE. coli is not mentioned at all \u2014 so it was also not identified.\n\nBut the options include both MRSA and E. coli.\n\nLooking back: the text says \"no MRSA\" in the lesional swab \u2014 so MRSA was not found.\n\nE. coli is not mentioned \u2014 so it was not found either.\n\nBut the only organism listed in the lesional swab that was not found is MRSA.\n\nE. coli is not mentioned in any swab at all \u2014 so it was not identified.\n\nBut in the text, under \"Lesional Skin Swab\", only Pseudomonas, Klebsiella, and Serratia are mentioned.\n\nTherefore, E. coli is not mentioned \u2014 so it was not identified.\n\nBut the question is which was NOT identified \u2014 and both MRSA and E. coli were not identified.\n\nHowever, in the swab results, MRSA is explicitly stated as absent in the lesional swab.\n\nE. coli is not mentioned at all \u2014 so it's not in the list.\n\nBut the question is about the lesional skin swab \u2014 and E. coli is not listed as being present or absent.\n\nTherefore, since E. coli is not mentioned, it was not identified.\n\nBut the answer choices include E. Escherichia coli.\n\nIn the text, E. coli is not mentioned in any swab.\n\nIn the \"Lesional Skin Swab\" section, only Pseudomonas, Klebsiella, and Serratia are mentioned.\n\nMRSA is explicitly stated to be absent.\n\nE. coli is not mentioned.\n\nSo both B (MRSA) and E (E. coli) were not identified.\n\nBut the question is: which was NOT identified?\n\nLooking at the options:\n\nA. Pseudomonas aeruginosa \u2014 identified (abundant)\n\nB. MRSA \u2014 not identified (no MRSA)\n\nC. Klebsiella oxytoca \u2014 identified (abundant)\n\nD. Serratia sp. \u2014 identified (abundant)\n\nE. Escherichia coli \u2014 not mentioned at all\n\nSo both B and E are correct in that they were not identified.\n\nBut the text says \"no MRSA\" \u2014 so MRSA was not identified.\n\nE. coli is not mentioned \u2014 so it was not identified.\n\nBut the only organism explicitly listed as absent in the lesional swab is MRSA.\n\nE. coli is not even in the list.\n\nHowever, the question is about the lesional skin swab \u2014 and E. coli is not mentioned.\n\nBut in the text, under \"Lesional Skin Swab\", only Pseudomonas, Klebsiella, and Serratia are listed.\n\nTherefore, E. coli was not identified.\n\nBut the answer must be one of the options.\n\nPerhaps the intended answer is MRSA, because it is explicitly stated as absent.\n\nE. coli is not mentioned, so it's not in the list.\n\nBut the question is: which was NOT identified?\n\nSince E. coli is not mentioned, it was not identified.\n\nBut in the text, under \"Lesional Skin Swab\", only the three are mentioned.\n\nTherefore, E. coli is not identified.\n\nBut let's check the exact text:\n\n\"Lesional Skin Swab: Abundant Pseudomonas aeruginosa, abundant Klebsiella oxytoca, and abundant Serratia sp.\"\n\nNo mention of E. coli.\n\nNo mention of MRSA \u2014 in fact, it says \"no MRSA\" in the swab.\n\nSo both B and E are not identified.\n\nBut the options are:\n\nA. Pseudomonas aeruginosa \u2014 present\n\nB. MRSA \u2014 absent\n\nC. Klebsiella oxytoca \u2014 present\n\nD. Serratia sp. \u2014 present\n\nE. Escherichia coli \u2014 not mentioned\n\nSo both B and E are correct.\n\nBut the question is multiple choice with one answer.\n\nThe text says \"no MRSA\" \u2014 so MRSA was not identified.\n\nE. coli is not mentioned \u2014 so it was not identified.\n\nBut in the context, the only organism explicitly not found in the swab is MRSA.\n\nE. coli is not in the list at all.\n\nHowever, the answer should be the one that was not identified.\n\nBut perhaps the intended answer is B, MRSA, because it is explicitly stated as absent.\n\nE. coli is not mentioned, so it's not in the data.\n\nBut in the list of organisms, E. coli is not present.\n\nAfter re-evaluating: the question is \"which bacterial organism was NOT identified\"\n\nIn the lesional skin swab, the following were identified:\n- Pseudomonas aeruginosa\n- Klebsiella oxytoca\n- Serratia sp.\n\nMRSA was not identified (absent).\n\nE. coli was not identified (not mentioned).\n\nBut the text does not say anything about E. coli.\n\nTherefore, E. coli was not identified.\n\nBut the only option that is explicitly stated as absent is MRSA.\n\nE. coli is not mentioned, so it's not in the results.\n\nBut the answer must be one.\n\nLooking at the text: in the \"MRSA Smears\" section, it says \"no MRSA\" in the lesional skin swab.\n\nSo MRSA was not identified.\n\nE. coli is not mentioned \u2014 so it was not identified.\n\nBut the question is about the lesional skin swab \u2014 and E. coli is not listed.\n\nHowever, the most direct answer from the text is that MRSA was not identified.\n\nE. coli is not mentioned in any swab.\n\nBut in the list of options, E. coli is included.\n\nPerhaps the intended answer is B.\n\nBut let's see: in the text, under \"Lesional Skin Swab\", only the three are mentioned.\n\nTherefore, E. coli is not identified.\n\nBut the answer is likely B, because MRSA is explicitly stated as absent.\n\nI think the correct answer is B, because the text says \"no MRSA\" in the lesional skin swab.\n\nE. coli is not mentioned, but it's not in the list of organisms found.\n\nBut the question is which was NOT identified \u2014 and both are not.\n\nHowever, since MRSA is explicitly stated as absent, and E. coli is not mentioned, but in the context of the swab, the only one explicitly absent is MRSA.\n\nI think the intended answer is B.\n\nFinal decision: B\n\nB"
    },
    {
      "question_id": "patient_07_q8",
      "generated_text": "The question asks for the TNM classification of Mrs. Linda Mayer's right breast condition after surgery on 09/01/2019.\n\nFrom the text, in text_3, under \"Histopathological Findings\" and \"Critical Findings Report\", it states:\n- \"Resected mammary segment with paracentral, max. 1.6 cm necrotic zone... and surrounding portions of ductal carcinoma in situ. Ductal carcinoma in situ, solid and rib-shaped growth type with comedonecrosis, WHO grade 3, nuclear grade 3. The resection was locally complete with the following Safety margins: ventral 0.15 cm, caudal 0.2 cm, dorsal 0.4 cm, and the remaining sedimentation margins more than 0.5 cm. TNM classification (8th edition 2017): pTis (DCIS), R0, G3.\"\n\nThis directly states the TNM classification is pTis (DCIS), R0, G3.\n\nTherefore, the correct answer is:\nB"
    },
    {
      "question_id": "patient_07_q9",
      "generated_text": "The question asks what was NOT found in the histopathological examination of the skin spindle from Mrs. Linda Mayer's mammary right scar.\n\nLooking at the relevant text (text_4, section \"Internal Histopathological Report\" under \"Skin spindle on scar mamma right\"):\n\n- \"Histologic skin/subcutaneous cross-sections with overlay by a multilayered keratinizing squamous epithelium\" \u2192 This was found.\n- \"Fibrosis and chronic inflammation\" \u2192 This was found.\n- \"No evidence of atypical epithelial infiltrates\" \u2192 This means atypical epithelial infiltrates were NOT found.\n- \"Sparse to moderately dense mononuclear-dominated inflammatory infiltrates\" \u2192 This was found.\n- \"Proliferation of collagenous and, in some places elastic fibers\" \u2192 This was found.\n\nTherefore, the correct answer is C, as atypical epithelial infiltrates were not found.\n\nC"
    },
    {
      "question_id": "patient_07_q10",
      "generated_text": "In July 2019, the medications listed for pain management include Tramadol/Naloxone (Ultram), Acetaminophen (Tylenol), and Naloxone (Narcan).\n\nIn January 2021, the medications listed include Prednisolone (Prelone), Acetaminophen (Tylenol), and Acyclovir (Zovirax), but not Tramadol/Naloxone (Ultram) or Naloxone (Narcan).\n\nTherefore, the medication used in July 2019 that was not listed in January 2021 is Tramadol/Naloxone (Ultram).\n\nA"
    },
    {
      "question_id": "patient_07_q11",
      "generated_text": "Step by step:\n\n1. We are looking for a medication whose dosing frequency was reduced in a second regimen (2021 vs 2019), indicating clinical improvement.\n\n2. In 2019 (text_0 and text_1):\n   - Prednisolone: 40mg oral, as advised (not a fixed frequency)\n   - Acyclovir: 800mg oral, 1-1-1 (daily)\n   - Aspirin: 100mg, 1-0-0 (daily)\n   - Simvastatin: 40mg, 0-1-0 (weekly)\n   - Pantoprazole: 40mg, 1-0-0 (daily)\n\n3. In 2021 (text_4):\n   - Prednisolone: 5 mg, 1.5-0-0-0-0-0 (less frequent, only every 1.5 days)\n   - Acyclovir: not mentioned\n   - Aspirin: 100mg, 0-1-0-0-0-0 (daily, but now only 1 dose per day)\n   - Simvastatin: 40mg, 0-0-0-0-1 (weekly)\n   - Pantoprazole: 45.1mg, 1-0-0-0-0 (daily)\n\n4. The only drug with a clear reduction in frequency is Prednisolone:\n   - 2019: 40mg as advised (implied daily or as needed)\n   - 2021: 5mg every 1.5 days (much less frequent)\n\n5. This reduction in dosing frequency suggests a significant clinical improvement, as prednisolone is a potent corticosteroid used for inflammation.\n\nAnswer: D"
    },
    {
      "question_id": "patient_07_q12",
      "generated_text": "The ink markings during the left subcutaneous mastectomy for Linda Mayer are described as follows: \"Blue/Ventral, Green/Cranial, Yellow/Caudal, Black/Dorsal\".\n\nCaudal margin is marked with yellow.\n\nC"
    },
    {
      "question_id": "patient_07_q13",
      "generated_text": "Mrs. Linda Mayer's diagnosis of breast carcinoma is mentioned in the text. In the section about her diagnosis, it states: \"Mrs. Mayer has been postmenopausal for eight years.\"\n\nTherefore, at the time of her diagnosis, she had been postmenopausal for 8 years.\n\nB"
    },
    {
      "question_id": "patient_07_q14",
      "generated_text": "Step 1: Identify the patient and relevant diagnosis. The patient is Mrs. Linda Mayer, and the diagnosis is breast carcinoma.\n\nStep 2: Look for allergy information in the text. In the text, under \"Other Diagnoses\" in multiple reports, it states: \"Notable allergy: Hay fever\".\n\nStep 3: Match the allergy to the options. Hay fever is option C.\n\nAnswer: C"
    },
    {
      "question_id": "patient_07_q15",
      "generated_text": "The question asks for the date of Mrs. Mayer's tumor board decision regarding her breast carcinoma diagnosis.\n\nLooking at the text, in text_0, we find a section titled \"Tumor board decision from 07/13/2019\" which directly states the date of the decision.\n\nTherefore, the correct answer is:\n\nA"
    },
    {
      "question_id": "patient_07_q16",
      "generated_text": "The question asks about the tumor resection margins for Mrs. Mayer's right breast surgery.\n\nLooking through the documents, in text_3, under the \"Histopathological Findings\" section, there is a detailed description of the right breast surgery:\n\n\"Resection margins were as follows: ventral 0.15 cm, caudal 0.2 cm, dorsal 0.4 cm, with remaining margins exceeding 0.5 cm.\"\n\nThis matches option B.\n\nB"
    },
    {
      "question_id": "patient_07_q17",
      "generated_text": "The question asks for Mrs. Mayer's platelet count at discharge. Looking through the documents, the relevant one is text_4, which contains the lab results upon discharge for Mrs. Linda Mayer. In that document, under \"Lab results upon Discharge,\" the platelet count is listed as 142 K/uL.\n\nA. 124 K/uL\nB. 224 K/uL\nC. 142 K/uL\nD. 242 K/uL\nE. 412 K/uL\n\nC"
    },
    {
      "question_id": "patient_07_q18",
      "generated_text": "The question asks for the concentration of prednicarbate cream used in Mrs. Mayer's treatment starting on 01/08/2021.\n\nLooking at the text, in text_6, under \"Current Recommendations\", it states: \"Topical therapy with petrolatum-based wound ointment and sterile compresses.\" and earlier: \"hydrophilic prednicarbate cream at 0.25% concentration, combined with octenidine at 0.1%, was applied to the neck and thighs twice daily, starting on 01/08/2021.\"\n\nThis clearly states the concentration is 0.25%.\n\nD"
    },
    {
      "question_id": "patient_07_q19",
      "generated_text": "Step 1: Identify the imaging procedures mentioned in the text for Mrs. Mayer.\n- Breast MRI (3T scanner) with dedicated mammary surface coil\n- Mammography and Tomosynthesis\n- CT thorax/abdomen\n- Digital Mammography\n\nStep 2: Determine the chronological order based on the text.\n- The text states: \"Mammography and Tomosynthesis from 07/8/2019: During the inspection and palpation, no significant findings were noted on either side. Some areas with higher mammographic density were observed... a small architectural irregularity was identified... This irregularity appeared as a small, roundish compression measuring approximately 6mm... no other suspicious focal findings were observed.\"\n- Then: \"MRI from 07/11/2019: Breast MRI (3T scanner) with dedicated mammary surface coil: The overall contrast enhancement was observed bilaterally to evaluate the Grade II findings.\"\n- Then: \"CT thorax/abdomen 07/12/2019: revealed a previously known liver lesion, likely a hemangioma. No evidence of metastases was identified. Nonspecific, small foci were observed in the lungs, likely indicative of post-inflammatory changes.\"\n- Then: \"Digital Mammography performed on 08/29/2019\" is mentioned in the surgical report, which is after the MRI and CT.\n\nStep 3: Order the procedures:\n- Mammography and Tomosynthesis (07/8/2019)\n- Breast MRI (07/11/2019)\n- CT thorax/abdomen (07/12/2019)\n- Digital Mammography (08/29/2019)\n\nStep 4: Match to the options.\nOnly option E includes all the procedures in the correct order.\n\nE"
    },
    {
      "question_id": "patient_08_q0",
      "generated_text": "The patient Laura Miller had osteoporotic vertebral body sintering, specifically noted in the thoracic and lumbar spine.\n\nIn the text, under \"Computed Tomography Thoracic spine from 05/22/2020\", it states: \"Fracture at the base plate of lumbar vertebra 2 with involvement of the posterior margin. Left lateral, no significant reduction in height of the vertebral body. No tension of the spine. Suspicion of new small fracture also at the cover plate at thoracic vertebra 8.\"\n\nThis directly identifies lumbar vertebra 2 (L2) and thoracic vertebra 8 (Th8).\n\nTherefore, the correct answer is:\n\nA. L2 and Th8"
    },
    {
      "question_id": "patient_08_q1",
      "generated_text": "Step 1: Identify the patient and relevant diagnosis. The patient is Laura Miller, diagnosed with liver cirrhosis.\n\nStep 2: Locate the CT of the thoracic spine in the provided text. In text <text_1>, under \"CT Thoracic spine from 05/22/2020\", the findings include: \"Multiple, older, osteoporotic compression fractures at the thoracic spine and upper lumbar spine.\"\n\nStep 3: Check for additional findings in the CT of the thoracic spine. The text also notes: \"Bilateral pleural effusions on both sides\" and \"Multiple endplate impressions in individual vertebrae of the lower thoracic spine.\"\n\nStep 4: Look for any of the listed options. Option E is \"Aortic sclerosis,\" which is explicitly mentioned in the text: \"Aortic sclerosis is present, along with degenerative changes throughout the thoracic vertebrae.\"\n\nStep 5: Confirm if any of the other options are mentioned. Option C (Gallbladder Hydrops) is mentioned in a different context (in liver MRI), not in the CT of the thoracic spine. Option D (Splenomegaly) is mentioned in other imaging, not specifically in the thoracic spine CT.\n\nConclusion: The additional finding noted in Laura Miller's CT of the thoracic spine is aortic sclerosis.\n\nE"
    },
    {
      "question_id": "patient_08_q2",
      "generated_text": "Step 1: Identify the relevant document for Laura Miller in May 2020. The text for \"text_1\" contains details about Laura Miller's treatment in May 2020.\n\nStep 2: Look for analgesia or pain management medications prescribed during that time. In text_1, under \"Therapy and Progression,\" it states: \"In the meantime, analgesia as needed using Acetaminophen 500mg 1-1-1 under gastric protection.\"\n\nStep 3: Confirm the medication. Acetaminophen is listed as the analgesic prescribed.\n\nStep 4: Match the option. Acetaminophen is the same as Paracetamol.\n\nAnswer: D"
    },
    {
      "question_id": "patient_08_q3",
      "generated_text": "Step 1: Identify the relevant information about Laura Miller's esophageal varices in the documents.\n\nStep 2: Look for mentions of Sarin's classification, which is referenced in the context of esophageal varices.\n\nStep 3: In text <text_1>, under the \"Esophagogastroduodenoscopy\" section, it states: \"Varices in the area of the cardia (GOV 1 after Sarin) were seen.\"\n\nStep 4: GOV stands for \"Gastroesophageal varices\" and GOV 1 indicates the classification according to Sarin's classification.\n\nStep 5: Therefore, the classification of Laura Miller\u2019s esophageal varices according to Sarin\u2019s classification is GOV1.\n\nA"
    },
    {
      "question_id": "patient_08_q4",
      "generated_text": "The question asks about imaging performed on Laura Miller on 06/13/2020.\n\nLooking at the text, on 06/13/2020, the following imaging is mentioned:\n- \"CT Chest/Abdomen/Pelvis with contrast agent from 06/18/2020\" \u2014 this is on 06/18/2020, not 06/13/2020.\n- \"Spine-whole: 2 planes from 06/13/2020\" \u2014 this is explicitly stated as occurring on 06/13/2020.\n\nTherefore, the correct imaging performed on 06/13/2020 is the spine-whole in 2 planes.\n\nD"
    },
    {
      "question_id": "patient_08_q5",
      "generated_text": "The thoracic spine kyphoplasty was performed on 06/14/2020, as stated in the text: \"On 06/14/2020, the planned surgery with kyphoplasty thoracic vertebra 8 under C-arm fluoroscopy could be performed without complications.\"\n\nB"
    },
    {
      "question_id": "patient_08_q6",
      "generated_text": "The total spine MRI plain was conducted on 06/13/2020, as stated in the text under \"Spine-whole: 2 planes from 06/13/2020\".\n\nC"
    },
    {
      "question_id": "patient_08_q7",
      "generated_text": "Laura Miller's inpatient treatments are listed in the reports. The last one is on 09/18/2020, which is when she was admitted for a follow-up examination for known esophageal varices.\n\nE"
    },
    {
      "question_id": "patient_08_q8",
      "generated_text": "The MR Liver plane + contrast agent report from 06/06/2020 lists the findings for lesion 1 and lesion 2. For lesion 1, the size is given as 41 mm. For lesion 2, the size is given as 104 mm. Since the question asks for the size of the largest lesion, we compare 41 mm and 104 mm. The largest is 104 mm.\n\n104 mm is equivalent to 10.4 cm.\n\nThe correct option is B.\n\nB"
    },
    {
      "question_id": "patient_08_q9",
      "generated_text": "Step 1: Identify the key date and context - The question asks about the liver board decision on 08/21/2020, which is during an inpatient admission for variceal screening.\n\nStep 2: Review the medical history - On 08/21/2020, Laura Miller underwent gastroscopy for variceal screening. The findings showed esophageal varices with alarm signs, and the procedure included 4 rubber band ligations.\n\nStep 3: Check for progression of disease - The text states that despite improvement in liver function with alcohol abstinence, there was a short-term progression of multifocal HCC without tumor-specific therapy, which led to the recommendation for repeat variceal screening.\n\nStep 4: Evaluate options - \n- A: New varices were found, but this was a screening finding, not a progression.\n- B: The progression of multifocal HCC is explicitly mentioned as a reason for the liver board decision.\n- C: No complications from banding are reported.\n- D: Improvement in liver function is noted, but not the reason for the decision.\n- E: No deterioration in nutritional status is mentioned.\n\nStep 5: Conclusion - The significant change that led to the liver board decision was the progression of multifocal HCC despite improved liver function.\n\nB"
    },
    {
      "question_id": "patient_08_q10",
      "generated_text": "Step 1: Identify the relevant Esophagogastroduodenoscopy (EGD) report for Laura Miller on 08/21/2020.\nStep 2: Look for findings related to esophageal varices or alarm signs.\nStep 3: In the EGD report from 08/21/2020, it states: \"Esophageal varices with alarm signs\" were observed, and 4 rubber band ligations were performed.\nStep 4: This matches option E.\n\nE"
    },
    {
      "question_id": "patient_08_q11",
      "generated_text": "The question asks for the date of a CT scan of the chest/abdomen/pelvis with contrast agent in Laura Miller.\n\nLooking through the text, we find a section titled \"CT Chest/Abdomen/Pelvis with contrast agent from 06/18/2020\" in the report about Mrs. Laura Miller.\n\nThis matches option C.\n\nA. May 28th 2020 - This is an EGD, not a CT scan.\nB. June 13th 2020 - This is a follow-up EGD.\nC. June 18th 2020 - This is the CT scan with contrast agent.\nD. June 15th 2020 - This is a thoracic spine scan.\nE. June 19th 2020 - This is a pathology report.\n\nC"
    },
    {
      "question_id": "patient_08_q12",
      "generated_text": "The question asks about a procedure performed on Laura Miller on 08/21/2020.\n\nLooking at the text, on 08/21/2020, the relevant entry is:\n\"Mrs. Miller presented electively for gastroscopy for variceal screening with continuation of banding therapy due to esophageal variceal bleeding.\"\n\nThe procedure described is an esophagogastroduodenoscopy (EGD) with banding therapy.\n\nOption C matches this description.\n\nA. MRI of the liver - not mentioned on that date.\nB. Ultrasound of the upper abdomen - mentioned on 05/27/2020.\nC. Esophagogastroduodenoscopy with banding therapy - matches the date and procedure.\nD. CT Chest/Abdomen/Pelvis with contrast - mentioned on 06/18/2020.\nE. Kyphoplasty of thoracic vertebra 8 - performed on 06/14/2020.\n\nAnswer: C"
    },
    {
      "question_id": "patient_08_q13",
      "generated_text": "The question asks for the date of the MR Liver plain + contrast agent examination for Laura Miller.\n\nLooking at the text, in the section about Laura Miller, under the \"MR Liver plain + contast agent from 06/06/2020\" entry, it clearly states the date as 06/06/2020.\n\nTherefore, the correct answer is:\n\nB"
    },
    {
      "question_id": "patient_08_q14",
      "generated_text": "The ultrasound of the abdomen showing liver cirrhosis was performed on 05/27/2020.\n\nE"
    },
    {
      "question_id": "patient_08_q15",
      "generated_text": "Step 1: Identify the relevant inpatient admission period - 09/18/2020 to 09/20/2020.\n\nStep 2: Review the diagnosis and conditions listed in the report for that specific admission.\n\nStep 3: The report states: \"Diagnoses: 4-time banding therapy with 4 rubber band ligations for residual esophageal varices without alarm signs\" - indicating residual varices.\n\nStep 4: The report also lists: \"Hepatocellular Carcinoma (HCC)\", \"Decompensated cirrhosis of the liver (Child B)\", \"Transfusion-dependent anemia\", and \"Arterial hypertension\".\n\nStep 5: All of these conditions are explicitly mentioned in the report.\n\nE"
    },
    {
      "question_id": "patient_08_q16",
      "generated_text": "The CT Thorax/Abdomen/Pelvis performed on 06/18/2020 noted bilateral minor pleural effusions with adjacent atelectasis.\n\nE"
    },
    {
      "question_id": "patient_08_q17",
      "generated_text": "Step by step:\n- The patient is Mrs. Laura Miller.\n- The consultation date is 06/08/2020.\n- The relevant text is from the report dated 06/08/2020.\n- In that report, under \"Nutritional counseling in cirrhosis of the liver,\" it states: \"Albumin at 2.6\" and \"Patient reports that she always a 'bad eater'\".\n- Albumin is a key protein marker; a value of 2.6 is below the normal range (typically 3.5\u20135.0 g/dL), indicating protein malnutrition.\n- The patient's self-reported eating habits and low albumin confirm inadequate nutrition.\n\nAnswer: C"
    },
    {
      "question_id": "patient_08_q18",
      "generated_text": "The question asks which medication was not ascertainably part of Mrs. Miller's regimen.\n\nLooking at the documents:\n\n- In text_0, it says: \"Current Medication (not fully collectible): Blood pressure medication, osteoporosis medication, no anticoagulation.\"\n- In text_1, it lists anticoagulation as not being used (no anticoagulation).\n- In text_2, it discusses nutritional advice, not medications.\n- In text_3, it discusses follow-up, not specific medications.\n- In text_4, it lists medications including prednisolone, aspirin, simvastatin, pantoprazole, etc., but no specific mention of pain relief or antibiotics.\n\nHowever, in text_0, it explicitly states \"no anticoagulation\" \u2014 meaning anticoagulation medication was not part of her regimen.\n\nThe other options (blood pressure, osteoporosis) are explicitly mentioned as \"not fully collectible\" or present in the text.\n\nPain relief medication and antibiotics are not specifically mentioned in the documents.\n\nBut the text says \"no anticoagulation\" \u2014 so that is clearly not part of her regimen.\n\nThe question is which was NOT ascertainably part of her regimen.\n\n\"Ascertainably\" means clearly known or documented.\n\nAnticoagulation is explicitly stated as absent.\n\nPain relief and antibiotics are not mentioned at all.\n\nBut in text_1, it mentions \"antibiotic intravenous therapy with ceftriaxone\" \u2014 so antibiotics were used.\n\nPain relief is not mentioned.\n\nBut in text_0, it says \"analgesia as needed using Acetaminophen\" \u2014 so pain relief was used.\n\nTherefore, pain relief was part of her regimen.\n\nAnticoagulation is explicitly stated as \"no anticoagulation\" \u2014 so it was not part of her regimen.\n\nAnswer: C\n\nC"
    },
    {
      "question_id": "patient_08_q19",
      "generated_text": "Step 1: Identify all radiology imaging exams mentioned in the text for Mrs. Laura Miller.\n\nExams listed:\n- X-ray thoracic and lumbar spine (05/22/2020)\n- CT thoracic spine (05/22/2020)\n- Abdominal ultrasound (05/27/2020)\n- Chest X-ray (05/28/2020)\n- MRI total spine (06/04/2020)\n- MRI liver plain + contrast agent (06/06/2020)\n- CT Chest/Abdomen/Pelvis with contrast agent (06/18/2020)\n\nNote: Esophagogastroduodenoscopy (EGD) is an endoscopy, not radiology imaging, so it should be excluded.\n\nStep 2: Extract the chronological order from the text.\n\nFrom the text:\n- 05/22/2020: X-ray thoracic and lumbar spine, CT thoracic spine, abdominal ultrasound\n- 05/28/2020: Chest X-ray\n- 06/04/2020: MRI total spine\n- 06/06/2020: MRI liver plain + contrast agent\n- 06/18/2020: CT Chest/Abdomen/Pelvis with contrast agent\n\nStep 3: Match the sequence to the options.\n\nOption D says:\n- Initial X-ray of thoracic and lumbar spine\n- CT scan of thoracic spine\n- Abdominal ultrasound - initial examination\n- Radiographic Chest X-ray\n- Abdominal ultrasound - follow-up\n- Plain MRI of liver\n- Complete Spine imaging in 2 planes\n- Total spine MRI\n- Comprehensive CT of Chest/Abdomen/Pelvis\n\nThis matches the sequence in the text, with the correct order and the inclusion of \"initial\" and \"follow-up\" for ultrasounds, though the MRI liver is listed as \"plain MRI of liver\" which is close to \"MRI liver plain\".\n\nOption D is the only one that correctly orders the radiology exams chronologically and includes all the exams.\n\nD"
    },
    {
      "question_id": "patient_09_q0",
      "generated_text": "The ultrasound on 07/26/2019 noted an \"approximately 8.3 x 6 cm echo-depleted mass\" in segment IV.\n\nC"
    },
    {
      "question_id": "patient_09_q1",
      "generated_text": "Step by step:\n\nThe question asks about the characteristics of hepatic masses seen on Mr. Wells' MRI of the liver on 07/26/2019.\n\nFrom the text (specifically text_0, which contains the MRI findings), the relevant paragraph states:\n\"MR imaging revealed the large, partly exophytic, partly centrally hemorrhagic HCC lesions in S3/4 and S7/8 to the illustration. In addition, complete enforcement of the left lobe of the liver was evident with smaller satellites and macroinvasion of the left portal vein branch. Mild cholestasis of the left biliary system.\"\n\nThen, under \"MRI of the liver plain + contrast agent from 07/26/2019\", the findings are described:\n\"Centrally hemorrhagic masses observed in liver segments 4, 7, and 8 demonstrate T2 hyperintensity, marked diffusion restriction, arterial phase enhancement, and venous phase washout. These characteristics are congruent with histopathological diagnosis of hepatocellular carcinoma.\"\n\nThis directly matches option B.\n\nAnswer: B"
    },
    {
      "question_id": "patient_09_q2",
      "generated_text": "The colonoscopy on 07/28/2019 found a 4mm polyp in the lower sigmoid colon, which was removed and histologically confirmed as minimally hyperplastic colorectal mucosa with no evidence of malignancy.\n\nB"
    },
    {
      "question_id": "patient_09_q3",
      "generated_text": "The report on 08/24/2019 mentions \"Liver fibrosis: Elevated alcohol consumption (3-4 beers/day).\" This indicates a history of alcohol abuse, which is a known risk factor for liver fibrosis, but it does not specify the stage of fibrosis (Stage 1-4).\n\nTherefore, the stage of liver fibrosis is not specified.\n\nE"
    },
    {
      "question_id": "patient_09_q4",
      "generated_text": "Step by step:\n\n- The question asks which complication Mr. Wells did NOT experience after Atezolizumab/Bevacizumab administration.\n- From the text, Mr. Wells received Atezolizumab/Bevacizumab starting on 08/24/2019.\n- Complications listed in the documents:\n  - Elevated transaminases (GPT 164 U/L, GOT 151 U/L) \u2192 B\n  - Worsening pulmonary status \u2192 C\n  - Severe pneumonic sepsis (in 10/2019) \u2192 D\n  - Oral burning \u2192 E\n- High blood pressure (hypertension) is listed as a pre-existing diagnosis (other diagnoses) and not specifically linked as a complication from the therapy.\n- Therefore, high blood pressure is not a complication of the drug administration but a chronic condition.\n\nAnswer: A"
    },
    {
      "question_id": "patient_09_q5",
      "generated_text": "The question asks for the date Mr. Wells was diagnosed with Community-Acquired Pneumonia (CAP).\n\nLooking through the documents:\n- In text_5, there is a report about Mr. Paul Wells from 02/04/2021 to 02/12/2021.\n- The diagnosis in that report is \"Community-Acquired Pneumonia (CAP)\".\n- The date of admission is 02/04/2021.\n\nThe other options are dates related to other diagnoses (HCC, systemic therapy, etc.), not CAP.\n\nTherefore, the correct answer is D.\n\nD"
    },
    {
      "question_id": "patient_09_q6",
      "generated_text": "The question asks for the causative pathogen of Mr. Wells' pneumogenic sepsis.\n\nLooking through the documents, in text_3, under the \"Medical History\" section, it states: \"Pneumogenic sepsis with detection of Streptococcus pneumoniae\".\n\nThis directly identifies Streptococcus pneumoniae as the pathogen.\n\nAnswer: B"
    },
    {
      "question_id": "patient_09_q7",
      "generated_text": "The MRI Liver on 11/20/2020 revealed stable findings in the liver. The previously identified HCC lesions in segments IV, VII/VIII, including their size and characteristics, remained largely unchanged. There was no evidence of new lesions or metastases.\n\nB"
    },
    {
      "question_id": "patient_09_q8",
      "generated_text": "The patient's medical history states he has COPD with a current severity level of Gold III.\n\nThis is confirmed in multiple reports, including the one dated 11/20/2020, which notes his COPD severity as Gold III.\n\nC\n\nC"
    },
    {
      "question_id": "patient_09_q9",
      "generated_text": "Step 1: Identify the relevant diagnosis for Mr. Wells. The patient has hepatocellular carcinoma (HCC), but the question asks about the condition that necessitated home oxygen therapy.\n\nStep 2: Review the medical history of Mr. Wells. In multiple reports, it is stated that Mr. Wells has COPD (chronic obstructive pulmonary disease), specifically with a Gold III severity level, and pulmonary emphysema.\n\nStep 3: Determine the cause of respiratory insufficiency. The reports consistently mention that he has respiratory partial insufficiency requiring home oxygen therapy due to COPD and pulmonary emphysema.\n\nStep 4: Among the options, \"Pulmonary Emphysema\" is directly listed as a diagnosis and is the underlying condition causing the need for home oxygen therapy.\n\nD"
    },
    {
      "question_id": "patient_09_q10",
      "generated_text": "Step 1: Identify the relevant patient and diagnosis. The patient is Mr. Paul Wells, and the diagnosis is Hepatocellular carcinoma (HCC).\n\nStep 2: Look for lab results related to GFR (Glomerular Filtration Rate) in the discharge records. In the text, under \"Lab results upon Discharge\" in the document titled \"text_3\", we find a parameter called \"GFR\".\n\nStep 3: Locate the GFR value. In the table under \"Lab results upon Discharge\" in text_3, the GFR value is listed as 36 mL/min.\n\nStep 4: Match the value to the options. Option D is 36 mL/min.\n\nAnswer: D"
    },
    {
      "question_id": "patient_09_q11",
      "generated_text": "Step 1: Identify the relevant patient and diagnosis. The patient is Mr. Paul Wells, born in 1953, with a diagnosis of hepatocellular carcinoma.\n\nStep 2: Locate the lab results upon discharge for Mr. Wells. This information is found in the text where it says: \"Lab results upon Discharge:\" and lists various parameters.\n\nStep 3: Find the total bilirubin level in the discharge lab results. In the provided text, under \"Lab results upon Discharge,\" the total bilirubin value is listed as 0.5 mg/dL.\n\nStep 4: Match the value to the options. Option A is 0.5 mg/dL, which matches the value.\n\nAnswer: A"
    },
    {
      "question_id": "patient_09_q12",
      "generated_text": "The patient was admitted on 07/26/2019 for suspected multifocal HCC. The first diagnostic procedure mentioned in the text is the \"Ultrasound-guided Liver Puncture\" which was performed on the same day. This was done to obtain tissue for histopathological examination. The CT and MRI scans were performed later as part of staging.\n\nC"
    },
    {
      "question_id": "patient_09_q13",
      "generated_text": "Step by step:\n\n1. The patient is Mr. Paul Wells, diagnosed with hepatocellular carcinoma (HCC) in July 2019.\n2. The diagnosis of HCC was confirmed in July 2019, and the tumor board recommended systemic therapy on 08/18/2019.\n3. The first administration of Atezolizumab/Bevacizumab is mentioned in the text: \"Initiation of Atezolizumab/Bevacizumab on 08/24/2019\".\n4. This date (08/24/2019) is explicitly stated in the document titled \"Paul Wells, born on 04/02/1953, who was under our outpatient treatment on 08/24/2019\".\n\nTherefore, the correct answer is:\n\nB"
    },
    {
      "question_id": "patient_09_q14",
      "generated_text": "Step by step:\n\n1. The question asks when Mr. Wells was first admitted for SIRT simulation.\n2. Looking through the documents, we find a report dated 08/13/2020 where it says: \"We assume familiarity with Mr. Wells' comprehensive medical history as described in the previous referral letter. At the time of admission, he reported significantly reduced physical performance due to his known severe COPD. Following the consensus of the Liver Board, we admitted Mr. Wells for a SIRT simulation.\"\n3. This confirms that the admission for SIRT simulation was on 08/13/2020.\n4. Other dates like 08/13/2019 or 07/26/2019 are related to other procedures (e.g., liver puncture, CT staging), not SIRT simulation.\n5. 10/24/2020 and 04/02/2021 are unrelated to SIRT simulation.\n\nAnswer: B"
    },
    {
      "question_id": "patient_09_q15",
      "generated_text": "The question asks for the sequence of imaging tests conducted on Mr. Paul Wells on 11/20/2020.\n\nFrom the text, on 11/20/2020, the following tests were performed:\n- MRI Liver (plain + contrast agent)\n- CT Chest/Abdomen/Pelvis with contrast agent\n- Gastroscopy\n- Colonoscopy\n\nThe text states: \"MRI Liver (plain + contrast agent) on 11/20/2020 09:01 AM\" and then \"CT Chest/Abdomen/Pelvis with contrast agent on 11/20/2020 12:45 PM\".\n\nThis clearly shows MRI Liver was done first, followed by CT Chest/Abdomen/Pelvis.\n\nGastroscopy and colonoscopy were also performed on the same day, but the sequence listed in the options is MRI followed by CT.\n\nTherefore, the correct sequence of imaging tests (as per the options) is MRI Liver followed by CT Chest/Abdomen/Pelvis.\n\nA"
    },
    {
      "question_id": "patient_09_q16",
      "generated_text": "The liver tumor board decision for systemic therapy was made on 08/18/2019, as stated in the text: \"Decision from the Liver Tumor Board on 08/18/2019: Recommending systemic therapy.\"\n\nB"
    },
    {
      "question_id": "patient_09_q17",
      "generated_text": "Step 1: Identify the first diagnostic procedures after Mr. Wells' admission on 07/26/2019.\n\nStep 2: From the text, the sequence is:\n- Ultrasound-guided liver puncture (performed on 07/26/2019)\n- MRI Liver (performed on 07/26/2019)\n- CT Chest/Abdomen/Pelvis (performed on 07/27/2019)\n\nStep 3: The ultrasound-guided puncture is the first procedure, followed by MRI, then CT.\n\nStep 4: Match this sequence to the options.\n\nOnly option A matches: Ultrasound-guided liver puncture, MRI Liver, CT Thorax/Abdomen/Pelvis.\n\nA"
    },
    {
      "question_id": "patient_09_q18",
      "generated_text": "Step 1: Identify the key therapy in question - Atezolizumab/Bevacizumab, an immune checkpoint inhibitor used for HCC.\n\nStep 2: Locate information about therapy interruptions in the text. Multiple documents mention pauses in therapy due to side effects.\n\nStep 3: Find specific details about the reason for pause. Text from text_3 and text_4 states: \"the patient experienced significant side effects, including oral burning, appetite and weight loss, low blood pressure, and worsening pulmonary status. Steroid treatment improved the pulmonary situation, but due to poor tolerance, therapy was paused after 02/14/2020.\"\n\nStep 4: Determine which option matches this. The key point is \"worsening pulmonary status\" requiring steroid treatment, which directly corresponds to option B.\n\nStep 5: Verify no other option fits better. Option D mentions liver function tests, but the text specifically notes pulmonary side effects and steroid use. Option C is about a bacterial infection, not a reason for therapy pause.\n\nB"
    },
    {
      "question_id": "patient_09_q19",
      "generated_text": "Step 1: Identify all radiology imaging exams mentioned in the documents for Mr. Paul Wells.\n\nExams listed:\n- Ultrasound (on 07/26/2019)\n- MRI of the liver (plain + contrast agent on 07/26/2019)\n- CT Chest/Abdomen/Pelvis with contrast agent (on 07/27/2019)\n- DSA Coeliac-Mesenteric (on 08/13/2020)\n- Perfusion Scintigraphy of the Liver and Lungs with SPECT/CT (on 08/13/2020)\n- MRI of the liver (again, on 11/20/2020)\n- CT Chest/Abdomen/Pelvis with contrast agent (on 11/20/2020)\n\nNote: Gastroscopy and colonoscopy are endoscopic procedures, not radiology imaging.\n\nStep 2: Eliminate non-radiology exams.\nGastroscopy and colonoscopy are not radiology exams, so they should be excluded.\n\nStep 3: Order the radiology exams chronologically.\n\n- Ultrasound: 07/26/2019\n- MRI liver: 07/26/2019 (same day as ultrasound, so after ultrasound)\n- CT Chest/Abdomen/Pelvis: 07/27/2019\n- DSA Coeliac-Mesenteric: 08/13/2020\n- Perfusion Scintigraphy: 08/13/2020 (same day as DSA)\n- MRI liver: 11/20/2020\n- CT Chest/Abdomen/Pelvis: 11/20/2020 (same day as MRI)\n\nSo the sequence is:\nUltrasound \u2192 MRI liver \u2192 CT Chest/Abdomen/Pelvis \u2192 DSA Coeliac-Mesenteric \u2192 Perfusion Scintigraphy \u2192 MRI liver \u2192 CT Chest/Abdomen/Pelvis\n\nStep 4: Match to options.\n\nOption A includes Gastroscopy and Colonoscopy (non-radiology) and has the wrong order (has CT before DSA, which is incorrect).\n\nOption B includes Gastroscopy and Colonoscopy (non-radiology) and has a wrong sequence.\n\nOption C: Ultrasound \u2192 MRI \u2192 CT \u2192 DSA \u2192 MRI \u2192 CT. This matches the timeline. The MRI and CT at the end are repeated, but the order is correct.\n\nOption D: DSA before CT, which is incorrect (DSA is after CT).\n\nOption E: DSA before CT, which is incorrect.\n\nOnly Option C has the correct chronological order of radiology exams.\n\nC"
    },
    {
      "question_id": "patient_10_q0",
      "generated_text": "Step by step:\n\n1. The patient is Mr. Peter Rudolph, born on 05/26/1954.\n2. The diagnosis mentioned is renal cell carcinoma, which aligns with the urothelial carcinoma of the renal pelvis.\n3. In the medical records, under \"Other Diagnoses\" and \"History\", it states: \"Atrial fibrillation: History of ablation in 2013\".\n4. This directly indicates that the atrial fibrillation ablation occurred in 2013.\n\nAnswer: C"
    },
    {
      "question_id": "patient_10_q1",
      "generated_text": "Step 1: Identify the relevant information about Mr. Peter Rudolph and the year 2010.\nStep 2: Look through the text for any procedure mentioned in 2010.\nStep 3: The text states: \"2010: pTCA stenting for acute myocardial infarction/CHD\"\nStep 4: This matches option B.\nStep 5: No other procedure is listed for 2010.\n\nB"
    },
    {
      "question_id": "patient_10_q2",
      "generated_text": "The diagnostic ureterorenoscopy was performed on 01/16/2019, as stated in the text: \"Diagnostic ureterorenoscopy on the left with biopsy and left DJ stent placement on 01/16/2019.\"\n\nA"
    },
    {
      "question_id": "patient_10_q3",
      "generated_text": "The question asks about the number of biopsies taken during Mr. Rudolph's ureterorenoscopy.\n\nLooking at the text for Mr. Peter Rudolph, in the report dated 01/16/2019, it states: \"During the procedure, a total of eight biopsies were successfully obtained from the ureter for histological evaluation.\"\n\nTherefore, the correct answer is 8.\n\nC"
    },
    {
      "question_id": "patient_10_q4",
      "generated_text": "The question asks which procedure was NOT performed on Mr. Rudolph on 01/16/2019.\n\nFrom the text about patient_10 (Peter Rudolph), on 01/16/2019, the procedures performed were:\n- Diagnostic ureterorenoscopy on the left\n- Biopsy of the left ureter\n- Retrograde urography on the left\n- DJ catheter placement on the left\n\nLaparoscopic cholecystectomy is mentioned in the medical history as a previous procedure (in 2012), not performed on 01/16/2019.\n\nTherefore, the correct answer is:\n\nE"
    },
    {
      "question_id": "patient_10_q5",
      "generated_text": "The question asks about the antibiotic used for antibacterial prophylaxis during Mr. Rudolph's ureterorenoscopy.\n\nLooking at the text, in the section titled \"Procedure\" under the report for Mr. Peter Rudolph on 01/16/2019, it states: \"The procedure was conducted under antibacterial prophylaxis with Ampicillin/Sulbactam 3g.\"\n\nThis directly answers the question.\n\nC"
    },
    {
      "question_id": "patient_10_q6",
      "generated_text": "The cytological report is mentioned in the text for Mr. Peter Rudolph in the context of his ureterorenoscopy on 01/16/2019. The internal cytological report specifically states: \"Internal Cytological Report Clinical Details: Sample Date: 01/16/2019\".\n\nTherefore, the date of the cytological report is 01/16/2019.\n\nB"
    },
    {
      "question_id": "patient_10_q7",
      "generated_text": "The internal cytological report mentions \"papillary arrangements of urothelial cells, some of which have peripheral hyperchromatic cell nuclei and altered nuclear-plasma ratios\" and \"numerous individual urothelial cells are also present with significantly rounded and enlarged cell nuclei, frequently in a peripheral location with hyperchromasia.\"\n\nThis indicates altered nuclear-plasma ratios, which is a pathological finding.\n\nB"
    },
    {
      "question_id": "patient_10_q8",
      "generated_text": "The histopathological report states: \"Extensive infiltration of a high-grade urothelial carcinoma in the renal pelvis with infiltration of the renal parenchyma and perihilar adipose tissue, maximum size 4.3 cm (1.).\"\n\nTherefore, the size of the left renal pelvis mass was 4.3 cm.\n\nC"
    },
    {
      "question_id": "patient_10_q9",
      "generated_text": "The liver metastasis in segment 7 was initially 4.2 x 2.5 cm on 03/03/2021. On 06/07/2021, it grew to 5.8 x 3.6 cm. The largest diameter increased from 4.2 cm to 5.8 cm, which is a growth of 1.6 cm.\n\nE"
    },
    {
      "question_id": "patient_10_q10",
      "generated_text": "The question asks which medication was NOT part of Mr. Rudolph's regimen upon discharge on 06/29/2021.\n\nLooking at the provided text for Mr. Rudolph on 06/29/2021, the medications listed upon discharge are:\n- Aspirin\n- Bisoprolol (Zebeta)\n- Pantoprazole (Protonix)\n- Prednisolone (Prelone)\n\nMetformin is not mentioned in any of the discharge medication lists.\n\nTherefore, the medication that was NOT part of his regimen is Metformin.\n\nE"
    },
    {
      "question_id": "patient_10_q11",
      "generated_text": "Step by step:\n\n1. Mr. Rudolph was diagnosed with urothelial carcinoma of the renal pelvis (not renal cell carcinoma) in March 2019.\n2. He underwent left nephroureterectomy in March 2019.\n3. Adjuvant chemotherapy with Gemcitabine/Cisplatin was given from April to July 2019 (4 cycles).\n4. In May 2020, he started immunotherapy with Nivolumab (240 mg q14d) for 10 cycles (May to September 2020).\n5. In October 2020 to June 2021, he received third-line chemotherapy with Vinflunin (external).\n6. In June 2021, a molecular tumor board found no molecular target, and Enfortumab Vedotin was mentioned as a possible option if desired, but not administered.\n7. No record shows Enfortumab Vedotin was actually given.\n\nThus, Enfortumab Vedotin has NOT been administered.\n\nE"
    },
    {
      "question_id": "patient_10_q12",
      "generated_text": "The Fist Closure Test was performed to assess for subclavian artery stenosis. The clinical findings described include bilateral triphasic flow in the subclavian and brachial arteries, normal flow in the left vertebral artery (no reversal), and no symptoms like arm claudication or dizziness. There were no signs of stenosis or flow reversal.\n\nA"
    },
    {
      "question_id": "patient_10_q13",
      "generated_text": "Step by step:\n\n- The question asks which item is NOT part of Mr. Rudolph's medical history.\n- We are given a list of diagnoses and procedures in the text related to Mr. Peter Rudolph.\n- Reviewing the options:\n  - A. Atrial fibrillation with ablation \u2192 mentioned in multiple reports (2013)\n  - B. pTCA stenting for acute myocardial infarction/CHD \u2192 mentioned (2010)\n  - C. Laparoscopic cholecystectomy \u2192 mentioned (2012)\n  - D. Left psoas abscess \u2192 mentioned (2019)\n  - E. Prostatectomy \u2192 never mentioned in any of the documents\n\nNo reference to prostatectomy exists in any of the provided medical reports.\n\nAnswer: E"
    },
    {
      "question_id": "patient_10_q14",
      "generated_text": "The last admission mentioned in the text is on 02/22/2022, where Mr. Rudolph was admitted for hernia repair. The medication prescribed upon admission for this admission is listed in the \"Medication upon Admission\" section: Aspirin, Bisoprolol (Zebeta), and Pantoprazole (Protonix).\n\nTherefore, the correct answer is A.\n\nA"
    },
    {
      "question_id": "patient_10_q15",
      "generated_text": "The question asks about the surgical procedure Mr. Rudolph underwent in February 2022.\n\nLooking at the text, in the entry for Mr. Peter Rudolph dated 02/22/2022 to 02/29/2022, it states:\n\"Operation: Alloplastic Incisional Hernia Repair in intubation anesthesia on 02/23/2022.\"\n\nThis directly answers the question.\n\nThe other options are either from earlier in his medical history or unrelated to the February 2022 procedure.\n\nAnswer: B"
    },
    {
      "question_id": "patient_10_q16",
      "generated_text": "Step 1: Identify the patient and diagnosis. The patient is Mr. Peter Rudolph, born 05/26/1954, diagnosed with urothelial carcinoma of the renal pelvis (not renal cell carcinoma as stated in the question). However, the question refers to \"Renal cell carcinoma,\" which may be a misstatement.\n\nStep 2: Look for chemotherapy regimens mentioned in the medical records. In the text, after the nephroureterectomy in March 2019, Mr. Rudolph underwent \"four cycles of adjuvant chemotherapy with Gemcitabine/Cisplatin.\"\n\nStep 3: Match the regimen to the options. Gemcitabine and Cisplatin is option D.\n\nStep 4: Confirm that this is the initial regimen post-diagnosis. Yes, it is stated as the first-line adjuvant therapy after surgery.\n\nD"
    },
    {
      "question_id": "patient_10_q17",
      "generated_text": "The question asks about the immunotherapy administered to Mr. Peter Rudolph from May to September 2020.\n\nLooking at the documents, in text_2, under \"Other Diagnoses\" and \"Medical History\", it states:\n\"05/20 - 09/20: 10 cycles of immunotherapy with Nivolumab 240 mg q14d.\"\n\nThis directly states that Mr. Rudolph received Nivolumab from May to September 2020.\n\nTherefore, the correct answer is D.\n\nD"
    },
    {
      "question_id": "patient_10_q18",
      "generated_text": "Step 1: Identify the medication plan on 06/29/2021 (before 02/22/2022).  \nFrom text_4: Medication on 06/29/2021 includes Aspirin, Bisoprolol, Pantoprazole, and Prednisolone.\n\nStep 2: Identify the medication plan on 02/22/2022 (after 06/29/2021).  \nFrom text_6: Medication upon admission includes Aspirin and Bisoprolol. Pantoprazole and Prednisolone are not listed.\n\nStep 3: Compare the two plans.  \nPantoprazole and Prednisolone are missing in the 02/22/2022 plan. Aspirin and Bisoprolol remain.\n\nStep 4: Choose the correct option.  \nThe change is that Pantoprazole and Prednisolone were removed.\n\nE"
    },
    {
      "question_id": "patient_10_q19",
      "generated_text": "The relevant imaging exams mentioned in the documents are:\n\n1. CT Thorax (plain) on 01/16/2019 - this is the first imaging.\n2. CT Chest/Abdomen/Pelvis with contrast agent on 06/07/2021 - this is a follow-up.\n3. CT-guided liver biopsy on 11/04/2020 - this is after the first CT and before the abdominal CT.\n4. External CT Abdomen dated 06/07/2021 - this is after the biopsy.\n\nSo the chronological sequence is:\n- Chest CT (01/16/2019)\n- CT-guided liver biopsy (11/04/2020)\n- Abdominal CT (06/07/2021)\n\nOption A matches this sequence.\n\nA"
    }
  ]
}